A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers

Clinical trial NCT06523803 · TERMINATED

Trial details

NCT number: NCT06523803
Sponsor: Zymeworks BC Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelin-expressing Advanced Cancers

Start date: 2024-09-30
Primary completion: 2025-09-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.